17beta-Estradiol but not the phytoestrogen naringenin attenuates aortic cholesterol accumulation in WHHL rabbits.
The effects of 17beta-estradiol (17beta-E(2)) or the phytoestrogen naringenin on spontaneous atherosclerosis were studied in 36 ovariectomized homozygous Watanabe heritable hyperlipidemic (WHHL) rabbits receiving a semisynthetic control diet; this diet added 0.0040% 17beta-E(2;) or 0.20% naringenin, for 16 weeks. The uterine weight was increased (P < 0.001) and the concentration of estrogen receptor alpha was decreased (P < 0.001) in the 17beta-E(2) group compared with the controls. Total plasma cholesterol and triglycerides were not different from those in the controls. In lipoproteins, HDL cholesterol was increased (P < 0.01), and LDL triglyceride and IDL triglyceride were lowered (P < 0.05). The oxidation (as concentration of malondialdehyde) was increased in LDL (P < 0.05) but not in plasma. The cholesterol accumulation was decreased (P < 0.05) in the ascending aorta and in the total aorta but the ratio of intima to media and area of intima in ascending, thoracic, and abdominal aorta were not significantly different. In the naringenin group the only differences, compared with the control group, were increased HDL cholesterol (P < 0.001) and decreased activity of glutathione reductase (P < 0.05). In conclusion, 17beta-E(2), but not naringenin, attenuated aortic cholesterol accumulation independently of plasma and LDL cholesterol. Further, these results support previously suggested pro-oxidant ability of 17beta-E(2) toward LDL and a possible connection between the pro-oxidant nature of 17beta-E(2) and its antiatherogenic effect.
Mortensen
A
A
Danish Veterinary and Food Administration, Institute of Food Safety and Toxicology, DK-2860 Søborg, Denmark. alm@fdir.dk
Breinholt
V
V
Dalsgaard
T
T
Frandsen
H
H
Lauridsen
S T
ST
Laigaard
J
J
Ottesen
B
B
Larsen
J J
JJ
D000818:Animals; D001011:Aorta / Q000033:anatomy & histology / Q000378:metabolism*; D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism; D002784:Cholesterol / Q000097:blood / Q000378:metabolism*; D004195:Disease Models, Animal; D004912:Erythrocytes / Q000201:enzymology; D004958:Estradiol / Q000097:blood / Q000494:pharmacology*; D004968:Estrogens, Non-Steroidal / Q000494:pharmacology*; D005260:Female; D044950:Flavanones; D005419:Flavonoids / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005526:Food, Formulated; D006801:Humans; D007529:Isoflavones; D008074:Lipoproteins / Q000097:blood; D015394:Molecular Structure; D010052:Ovariectomy; D010084:Oxidation-Reduction; D048789:Phytoestrogens; D028321:Plant Preparations; D011817:Rabbits
D004968:Estrogens, Non-Steroidal; D044950:Flavanones; D005419:Flavonoids; D007529:Isoflavones; D008074:Lipoproteins; D048789:Phytoestrogens; D028321:Plant Preparations; D004958:Estradiol; D002784:Cholesterol; C005273:naringenin